..:: Pacific Heart Lung & Blood Institute ::..

Dr. Harvey Pass

Curriculum Vitae

Background Information
Full Name:		Harvey I. Pass M.D.
Academic Title:		Professor and Chief Division of Thoracic Surgery and Thoracic Oncology
Work Address:		NYU School of Medicine and Comprehensive Cancer Center 530 1st Avenue, 9V New York, New York 10016
Telephone:		(310) 794-7333 (office) (310) 794-7335 (fax)

Faculty Appointments
Assistant Professor
Institution:		Medical University of South Carolina Division of Cardiothoracic Surgery Charleston, South Carolina
Senior Staff Fellow, Thoracic Oncology Section
Institution:		Surgery Branch National Cancer Institute/NIH, Bethesda
Assistant Professor of Surgery
Institution:		Uniformed Services University of the Health Sciences Bethesda, Maryland
Head, Thoracic Oncology Section and Tenured Senior Investigator
Institution:		Surgery Branch, National Cancer Institute Bethesda, Maryland
Education
Medical Education
Institution: Location: Attendance:		Duke University Medical School Durham, North Carolina, 1970-1973, M.D.
Undergraduate Education
Institution: Location: Attendance:		Johns Hopkins University, Baltimore, Maryland 1967-1970 , B.A.
Training
1973-1974		Duke University Medical Center Straight Surgical Internship
1974-1975		Duke University Medical Center Straight Surgical Residency
1975-1977		United States Public Health Service Hospital Staten Island, New York Staff Surgeon
1977-1980		University of Mississippi Medical Center Senior and Chief Resident Division of Surgery
1980-1982		Medical University of South Carolina Senior Residency and Chief Resident Division of Cardiothoracic Surgery

Major Professional Societies:

American Surgical Association
Association of Military Surgeons
Association of Academic Surgeons
Society of Thoracic Surgeons
Society for Surgical Oncology
Fellow of the American College of Surgeons
Southern Thoracic Surgical Association
Society of University Surgeons
Surgical Biology Club III
American College of Chest Physicians
American Association of Thoracic Surgeons
International Mesothelioma Group
International Association for the Study of Lung Cancer
International Early Lung Cancer Action Project
International Working Group on Pulmonary Metastases
American Society of Clinical Oncology
American Association for Cancer Research
Thoracic Surgery Club

Licensure and Board Certification:

1974 - National Board of Medical Examiners
1981 - American Board of Surgery
1983 - American Board of Thoracic Surgery
1992 - American Board of Thoracic Surgery (recertified)
2001 - American Board of Thoracic Surgery (recertified)

Honors and Awards:

1967 - Cum Laude (High School)
1970 - Alpha Epsilon Delta, Pre Medical Society
Phi Beta Kappa,Johns Hopkins University
1979 - Mississippi Regional Trauma Award, First Place Winner Annual Meeting of the Mississippi Medical Society
1980 - Conrad Jobst Award, First Place Winner, Southeast Surgical Congress
"Comparison of External and Internal Cardiac Massage"
1983 - Conrad Jobst Award, Third Place Winner, Southeast Surgical Congress
"Augmentation of External Cardiac Massage with the Mast Suit"
1984 - Rowe Foundation Award for outstanding article by an Institution-Based Physician in the Journal of the South Carolina Medical Association, "Radioactive Microspheres: A useful tool in the investigation of myocardial ischemia".
1989 - President's Award, Southern Thoracic Surgical Association
1991 - NIH Directors Award
1992 - Best Doctors in America (Naifeh S and Smith G, eds): Thoracic Oncologic Surgery
1992 - Best Cancer Specialists in the U.S. Good Housekeeping, October 1992
1995 - Hufnagle Award for benchwork research performed by a Georgetown General Surgery Resident
1996 - First Place: Washington Academy of Sciences Award
1999 - 318 Best Cancer Specialists for Women in the U.S. Good Housekeeping, March 1999
2000 - Presidents Award for Clinical Research, Karmanos Cancer Institute
2001 - America’s Top Doctors. Castle Connoly’s Guide
2002 - America’s Top Doctors. Castle Connoly’s Guide

SERVICE:

1. Patient Care: General and Cardiothoracic Surgery, specifically Thoracic Oncology

2. Professional Consultation:

a. Public presentations as an expert in discipline
Mesothelioma. Defense Research Institute Meeting. New York, NY, 1994

b. Testimony before public bodies:
Defense of PDT for Lung Cancer: ODAC meeting, FDA, September 1997
Defense of PDT for Lung Cancer: ODAC meeting, FDA, September 1998

c.. Consulting to public agencies, foundations, professional associations
Site visit Member for review of the Lung Cancer Study Group, 1986
Surgical expert and speaker for ALCASE, 1998
Chairman, Scientific Advisory Board, Mesothelioma Applied Research Foundation (MARF)
Medical Advisory Board, ALCASE 2000 -

d. Consulting to private enterprises:
Light Medicine, Inc.
PDT Inc.
Pharmacyclics
Quadra Logics Technologies
Jansen Pharmacia
Chiron-Bayer
Sanofi Pharmaceuticals
Alfacell
Battelle
Xillix
Lilly

3. Journal/Editorial activity

a. Editorships
Guest Editor: Adjunctive and Alternative Treatment of Bronchogenic Lung Cancer,
Chest Surgery Clinics of North America, 1:1, August 1991
Surgical Editor, Clinical Lung Cancer , 2001-
Thoracic Surgery Editor, Annals of Surgical Oncology, 2003-

b. Editorial board memberships:

Journal of the National Cancer Institute, 1990-1994
Annals of Surgical Oncology, 1993-
Surgical Oncology, 1993-
Journal of Surgical Research, 1995-2003
Clinical Lung Cancer, 1999-
Current Treatment Options in Oncology, 1999-
Clinical Cancer Research, 2001-

c. Guest reviewer:

Cancer Research
Annals of Thoracic Surgery
Journal of Thoracic and Cardiovascular Surgery
Chest
British Medical Journal
New England Journal of Medicine
Journal of Clinical Oncology
JAMA
Clinical Cancer Research
The Cancer Journal of Scientific American
Cancer
Clinical Cancer Research
The Oncologist
International Journal of Cancer
Clinical Lung Cancer
Journal of the National Cancer Institute
Oncogene

4. Other professionally related service

1997 - Karmanos Cancer Institute Program Leader, Thoracic Oncology
1997 - Karmanos Cancer Institute Clinical Cancer Trials Committee
2002 – Karmanos Cancer Institute Associate Director for Clinical Research
2002 – Karmanos Cancer Institute CEO and President Search Committee

5. National and international boards and committees

a. Positions held in professional associations

1991 - 1996 NCI representative, American Joint Commission on Cancer
1991 - 1994 Program Committee, Southern Thoracic Surgical Association
1991 - 1995 Consultant, American Board of Thoracic Surgeons
1995 - 1997 Counselor at Large, Southern Thoracic Surgical Association
1996 - 1998 Young Members Committee, American Association of Thoracic Surgeons
1998 - 2000 Residents Committee, American Association of Thoracic Surgeons
1998 - 2000 Thoracic Surgery Foundation for Research and Education, Finance committee
1998- Executive Committee, International Mesothelioma Interest Group
1999- Chairman, Scientific Advisory Board, Mesothelioma Applied Research Foundation (MARF)
2001- Scientific Program Committee: International Association for the Study of Lung Cancer
2001- Lung Committee, American Society for Clinical Oncology

b. Memberships/offices held in public agencies related to discipline:

1997 - Michigan Lung Cancer Advisory Committee
1998 - Michigan Thoracic Society
1998 - Detroit Academy of Surgery
1998 - Detroit Surgical Association

6. State and local boards and committees:

1997 - Michigan Lung Cancer Advisory Committee
1997 - Chairman, Detection/Screening of Lung Cancer, Michigan Lung Cancer Advisory Committee

Teaching:

1. Years at Wayne State: 7.0

2. Years at other colleges/universities

1982 - 1983
Assistant Professor Medical University of South Carolina
Division of Cardiothoracic Surgery
Charleston, South Carolina

1983 - 1996
Assistant Professor of Surgery
Uniformed Services University of the Health Sciences Bethesda, Maryland

3. Courses taught at Wayne State in last five years: Cancer Biology

4. Essays/Theses/Dissertations directed: none

5. Course or Curriculum development:

a. Early Lung Cancer: Strategic Initiatives for Molecular Diagnosis and Treatment, Sommersett Inn, June 15-17, 2000

6. Course materials (unpublished): none

Grant Support:

(Pass, H, Principal Investigator) Olympus America	04/01/99 - 10/01/01 $20,000	10%
Use of Sputum Induction and Fluorescence Bronchoscopy for Airway Surveillance and Study of Intermediate Markers of Neoplasia in Asbestos Exposed Individuals

(Pass, H, Principal Investigator)	10/98 - 10/01	20%
Department of Veterans Affair Merit Review Detection of SV40 Like Viral DNA in Human Mesothelioma	$93,000/year x 3 years

(Pass, H, Principal Investigator) INSPIRE Pharmaceuticals	05/00 – 04/01 $32,593.75	2%
Evaluation of Uridine 5’-Triphosphate Solution for Inhalation (UTP) as an Adjunct in the Diagnosis of Lung Cancer by Sputum Cytology

(Pass, H, Principal Investigator) Eli Lilly and Company	07/99 – 06/02 $3,668/patient	2%
A single-blind randomized phase 3 trial of MTA plus Cisplatin versus Cisplatin with malignant pleural mesothelioma

(Kucuk, O, Principal Investigator) Pass, H, Co-Investigator	01/01 – 06/30/03 $758,959/year	20%
NO1-CN-05022-57 NIH Masters Agreement Work Statement #68 Zileuton for Bronchial Dysplasia

(Pass, H, Principal Investigator)	01/01 -
Rapid Assessment for Intervention Development (RAID) NIH Contractual Agreement- approximately $1.4 million Use of Vac-Tag for Malignant Pleural Mesothelioma

(Schwartz, A.) Pass, H, Co-Investigator	07/01/00 – 06/30/05 $400,000	5%
NCI Adenocarcinoma of the Lung in Women

(Pass, H.)	4/01/01-3/31-02	10%
NCI-Early Detection Research Network (Part of UO1) Gene Arrays and Methylation in Mesothelioma	$100,000

(Phillips, M, Principal Investigator) (Pass, H Consultant)	7/01/01-06/30/03 $700,000
NCI-SBIR Detection of Lung Cancer using Exhaled Gas Determination

(Pass, H, Principal Investigator)	4/2002-3/2005
Veterans Administration, Merit Review Osteonectin and TIMP1 in Mesothelioma	$363,900

(Pass, H, Principal Investigator)	11/2001 – 7/2003
KCI Virtual Discovery Grant Racial Differences in Lung Cancer	$330,000

(Wali, A Principal Investigator; Pass H Co-Investigator)	4/2003-3/2006
Veterans Administration Merit Review Intellectin Expression in Mesothelioma	$398,000

Publications

Original observations in refereed journals

1. Friedberg, J. S., Mick, R., Stevenson, J., Metz, J., Zhu, T., Buyske, J., Sterman, D. H., Pass, H. I., Glatstein, E., and Hahn, S. M. A phase I study of Foscan-mediated photodynamic therapy and surgery in patients with mesothelioma. Ann.Thorac.Surg., 75: 952-959, 2003.

2. Lonardo, F., Pass, H. I., and Lucas, D. R. Immunohistochemistry Frequently Detects c-Kit Expression in Pulmonary Small Cell Carcinoma and May Help Select Clinical Subsets for a Novel Form of Chemotherapy. Appl.Immunohistochem.Mol.Morphol., 11: 51-55, 2003.

3. Lucas, D. R., Pass, H. I., Madan, S. K., Adsay, N. V., Wali, A., Tabaczka, P., and Lonardo, F. Sarcomatoid mesothelioma and its histological mimics: a comparative immunohistochemical study. Histopathology, 42: 270-279, 2003.

4. Bocchetta, M., Miele, L., Pass, H. I., and Carbone, M. Notch-1 induction, a novel activity of SV40 required for growth of SV40-transformed human mesothelial cells. Oncogene, 22: 81-89, 2003.

5. Pass, H. I. General thoracic surgery and science: it all takes time. Ann.Thorac.Cardiovasc.Surg., 8: 251-252, 2002.

6. Pass, H. I. Pleural mesothelioma in 2002: going somewhere very slowly. J Thorac.Cardiovasc.Surg., 124: 1074-1077, 2002.

7. Friedel, G., Pastorino, U., Ginsberg, R. J., Goldstraw, P., Johnston, M., Pass, H., Putnam, J. B., and Toomes, H. Results of lung metastasectomy from breast cancer: prognostic criteria on the basis of 467 cases of the International Registry of Lung Metastases. Eur.J Cardiothorac.Surg., 22: 335-344, 2002.

8. Pass, H. I. Photodynamic therapy in thoracic surgery. Ann.Thorac.Surg., 73: 2012-2013, 2002.

9. Lechner, J. F., Wang, Y., Siddiq, F., Fugaro, J. M., Wali, A., Lonardo, F., Willey, J. C., Harris, C. C., and Pass, H. I. Human lung cancer cells and tissues partially recapitulate the homeobox gene expression profile of embryonic lung. Lung Cancer, 37: 41-47, 2002.

10. Pass, H. I. Biology of metastatic disease. Semin.Thorac.Cardiovasc.Surg., 14: 10-17, 2002.

11. Bright, R. K., Kimchi, E. T., Shearer, M. H., Kennedy, R. C., and Pass, H. I. SV40 Tag-specific cytotoxic T lymphocytes generated from the peripheral blood of malignant pleural mesothelioma patients. Cancer Immunol.Immunother., 50: 682-690, 2002.

12. Foddis, R., De Rienzo, A., Broccoli, D., Bocchetta, M., Stekala, E., Rizzo, P., Tosolini, A., Grobelny, J. V., Jhanwar, S. C., Pass, H. I., Testa, J. R., and Carbone, M. SV40 infection induces telomerase activity in human mesothelial cells. Oncogene, 21: 1434-1442, 2002.

13. Marom, E. M., Erasmus, J. J., Pass, H. I., and Patz, E. F., Jr. The role of imaging in malignant pleural mesothelioma. Semin.Oncol, 29: 26-35, 2002.

14. Carbone, M. and Pass, H. I. Re: Debate on the link between SV40 and human cancer continues. J Natl.Cancer Inst., 94: 229-230, 2002.

15. Toyooka, S., Pass, H. I., Shivapurkar, N., Fukuyama, Y., Maruyama, R., Toyooka, K. O., Gilcrease, M., Farinas, A., Minna, J. D., and Gazdar, A. F. Aberrant methylation and simian virus 40 tag sequences in malignant mesothelioma. Cancer Res., 61: 5727-5730, 2001.

16. Pass, H. I., Kalemkerian, G., and Bright, R. K. Novel molecular and immunotherapeutic strategies for lung cancer. Chest Surg.Clin N.Am., 11: 189-212, ix, 2001.

17. Imperiale, M. J., Pass, H. I., and Sanda, M. G. Prospects for an SV40 vaccine. Semin.Cancer Biol., 11: 81-85, 2001.

18. Rizzo, P., Bocchetta, M., Powers, A., Foddis, R., Stekala, E., Pass, H. I., and Carbone, M. SV40 and the pathogenesis of mesothelioma. Semin.Cancer Biol., 11: 63-71, 2001.

19. Lechner, J. F., Fugaro, J. M., Wong, Y., Pass, H. I., Harris, C. C., and Belinsky, S. A. Perspective: cell differentiation theory may advance early detection of and therapy for lung cancer. Radiat.Res., 155: 235-238, 2001.

20. Wang, Y., Fugaro, J. M., Siddiq, F., Goparaju, C. M., Lonardo, F., Wali, A., Lechner, J. F., and Pass, H. I. A simple method for generating full length cDNA from low abundance partial genomic clones. BMC.Mol.Biol., 1: 2, 2000.

21. Bocchetta, M., Di, R., I, Powers, A., Fresco, R., Tosolini, A., Testa, J. R., Pass, H. I., Rizzo, P., and Carbone, M. Human mesothelial cells are unusually susceptible to simian virus 40-mediated transformation and asbestos cocarcinogenicity. Proc.Natl.Acad.Sci.U.S.A, 97: 10214-10219, 2000.

22. Marrogi, A., Pass, H. I., Khan, M., Metheny-Barlow, L. J., Harris, C. C., and Gerwin, B. I. Human mesothelioma samples overexpress both cyclooxygenase-2 (COX-2) and inducible nitric oxide synthase (NOS2): in vitro antiproliferative effects of a COX-2 inhibitor. Cancer Res., 60: 3696-3700, 2000.

23. Carbone, M., Rizzo, P., and Pass, H. Simian virus 40: the link with human malignant mesothelioma is well established. Anticancer Res., 20: 875-877, 2000.

24. Pass, H. I. Lung cancer surveillance: new technologies and novel strategies. Ann.Surg.Oncol, 7: 171-173, 2000.

25. Shivapurkar, N., Wiethege, T., Wistuba, I. I., Salomon, E., Milchgrub, S., Muller, K. M., Churg, A., Pass, H., and Gazdar, A. F. Presence of simian virus 40 sequences in malignant mesotheliomas and mesothelial cell proliferations. J Cell Biochem., 76: 181-188, 1999.

26. Rizzo, P., Carbone, M., Fisher, S. G., Matker, C., Swinnen, L. J., Powers, A., Di, R., I, Alkan, S., Pass, H. I., and Fisher, R. I. Simian virus 40 is present in most United States human mesotheliomas, but it is rarely present in non-Hodgkin's lymphoma. Chest, 116: 470S-473S, 1999.

27. Pass, H. I., Robinson, B. W., Testa, J. R., and Carbone, M. Emerging translational therapies for mesothelioma. Chest, 116: 455S-460S, 1999.

28. Herscher, L. L., Cook, J. A., Pacelli, R., Pass, H. I., Russo, A., and Mitchell, J. B. Principles of chemoradiation: theoretical and practical considerations. Oncology (Huntingt), 13: 11-22, 1999.

29. Hirvonen, A., Mattson, K., Karjalainen, A., Ollikainen, T., Tammilehto, L., Hovi, T., Vainio, H., Pass, H. I., Di, R., I, Carbone, M., and Linnainmaa, K. Simian virus 40 (SV40)-like DNA sequences not detectable in finnish mesothelioma patients not exposed to SV40-contaminated polio vaccines. Mol.Carcinog., 26: 93-99, 1999.

30. Ohta, Y., Shridhar, V., Bright, R. K., Kalemkerian, G. P., Du, W., Carbone, M., Watanabe, Y., and Pass, H. I. VEGF and VEGF type C play an important role in angiogenesis and lymphangiogenesis in human malignant mesothelioma tumours. Br.J Cancer, 81: 54-61, 1999.

31. Shridhar, V., Staub, J., Huntley, B., Cliby, W., Jenkins, R., Pass, H. I., Hartmann, L., and Smith, D. I. A novel region of deletion on chromosome 6q23.3 spanning less than 500 Kb in high grade invasive epithelial ovarian cancer. Oncogene, 18: 3913-3918, 1999.

32. Giuffrida, A., Vianale, G., Di Muzio, M., Pass, H. I., Coletti, A., Birarelli, P., Procopio, A., and Modesti, A. Modulation of integrin expression on mesotheliomas: the role of different histotypes in invasiveness. Int.J Oncol, 15: 437-442, 1999.

33. Carbone, M., Fisher, S., Powers, A., Pass, H. I., and Rizzo, P. New molecular and epidemiological issues in mesothelioma: role of SV40. J Cell Physiol, 180: 167-172, 1999.

34. Ohta, Y., Shridhar, V., Kalemkerian, G. P., Bright, R. K., Watanabe, Y., and Pass, H. I. Thrombospondin-1 expression and clinical implications in malignant pleural mesothelioma. Cancer, 85: 2570-2576, 1999.

35. Scarpa, S., Giuffrida, A., Fazi, M., Coletti, A., Palumbo, C., Pass, H. I., Procopio, A., and Modesti, A. Migration of mesothelioma cells correlates with histotype-specific synthesis of extracellular matrix. Int.J Mol.Med., 4: 67-71, 1999.

36. Xu, L., Flynn, B. J., Ungar, S., Pass, H. I., Linnainmaa, K., Mattson, K., and Gerwin, B. I. Asbestos induction of extended lifespan in normal human mesothelial cells: interindividual susceptibility and SV40 T antigen. Carcinogenesis, 20: 773-783, 1999.

37. Friedel, G., Pastorino, U., Buyse, M., Ginsberg, R. J., Girard, P., Goldstraw, P., Johnston, M., McCormack, P., Pass, H., Putnam, J. B., and Toomes, H. [Resection of lung metastases: long-term results and prognostic analysis based on 5206 cases--the International Registry of Lung Metastases]. Zentralbl.Chir, 124: 96-103, 1999.

38. Watts, A. M., Shearer, M. H., Pass, H. I., Bright, R. K., and Kennedy, R. C. Comparison of simian virus 40 large T antigen recombinant protein and DNA immunization in the induction of protective immunity from experimental pulmonary metastasis. Cancer Immunol.Immunother., 47: 343-351, 1999.

39. DeLaney, T. F., Smith, P. D., Thomas, G. F., Tochner, Z. A., Sindelar, W. F., Pass, H. I., Harrington, F. S., Bonner, R. F., and Mitchell, J. B. A light-diffusing device for intraoperative photodynamic therapy in the peritoneal or pleural cavity. J Clin Laser Med.Surg., 9: 361-366, 1991.

40. Pass, H. I. Pancreatic cancer, gene delivery, and targets: the search for specificity. Ann.Surg.Oncol, 5: 667-669, 1998.

41. Pass, H. I., Donington, J. S., Wu, P., Rizzo, P., Nishimura, M., Kennedy, R., and Carbone, M. Human mesotheliomas contain the simian virus-40 regulatory region and large tumor antigen DNA sequences. J Thorac.Cardiovasc.Surg., 116: 854-859, 1998.

42. Bright, R. K., Shearer, M. H., Pass, H. I., and Kennedy, R. C. Immunotherapy of SV40 induced tumours in mice: a model for vaccine development. Dev.Biol.Stand., 94: 341-353, 1998.

43. Pass, H. I., Mew, D. J., Carbone, M., Donington, J. S., Baserga, R., and Steinberg, S. M. The effect of an antisense expression plasmid to the IGF-1 receptor on hamster mesothelioma proliferation. Dev.Biol.Stand., 94: 321-328, 1998.

44. Carbone, M., Stach, R., Di, R., I, Pass, H. I., and Rizzo, P. Simian virus 40 oncogenesis in hamsters. Dev.Biol.Stand., 94: 273-279, 1998.

45. Pass, H., Rizzo, P., Donington, J., Wu, P., and Carbone, M. Further validation of SV40-like DNA in human pleural mesotheliomas. Dev.Biol.Stand., 94: 143-145, 1998.

46. Rizzo, P., Di, R., I, Stach, R., Mutti, L., Picci, P., Kast, W. M., Pass, H. I., and Carbone, M. Evidence for and implications of SV40-like sequences in human mesotheliomas and osteosarcomas. Dev.Biol.Stand., 94: 33-40, 1998.

47. Temeck, B. K., Wexler, L. H., Steinberg, S. M., McClure, L. L., Horowitz, M. A., and Pass, H. I. Reoperative pulmonary metastasectomy for sarcomatous pediatric histologies. Ann.Thorac.Surg., 66 : 908-912, 1998.

48. Rizzo, P., Di, R., I, Powers, A., Matker, C. M., Zhang, A., Mutti, L., Kast, W. M., Pass, H., and Carbone, M. The detection of simian virus 40 in human tumors by polymerase chain reaction. Monaldi Arch.Chest Dis., 53: 202-210, 1998.

49. Matker, C. M., Rizzo, P., Pass, H. I., Di, R., I, Powers, A., Mutti, L., Kast, W. M., and Carbone, M. The biological activities of simian virus 40 large-T antigen and its possible oncogenic effects in humans. Monaldi Arch.Chest Dis., 53: 193-197, 1998.

50. Sgrignoli, A., Abati, A., Pass, H., Lebovics, R., and Hijazi, Y. Metastatic mesothelioma presenting as a salivary gland neoplasm. Acta Cytol., 42: 818-820, 1998.

51. Pass, H. I. Surgical management of pulmonary metastases. Curr.Opin.Oncol, 10: 146-150, 1998.

52. Shaw, G. L., Falk, R. T., Frame, J. N., Weiffenbach, B., Nesbitt, J. C., Pass, H. I., Caporaso, N. E., Moir, D. T., and Tucker, M. A. Genetic polymorphism of CYP2D6 and lung cancer risk. Cancer Epidemiol.Biomarkers Prev., 7: 215-219, 1998.

53. Williams, K. S., Susla, G., Temeck, B. K., Piscitelli, S. C., and Pass, H. I. Pharmacokinetics of fentanyl during hyperthermic, isolated lung perfusion. South.Med.J, 91: 261-265, 1998.

54. Pass, H. I. and Temeck, B. A. Biology of metastatic disease. Chest Surg.Clin N.Am., 8: 1-11, 1998.

55. Watts, A. M., Shearer, M. H., Pass, H. I., and Kennedy, R. C. Development of an experimental murine pulmonary metastasis model incorporating a viral encoded tumor specific antigen. J Virol.Methods, 69: 93-102, 1997.

56. Pass, H. I., Temeck, B. K., Kranda, K., Steinberg, S. M., and Feuerstein, I. R. Preoperative tumor volume is associated with outcome in malignant pleural mesothelioma. J Thorac.Cardiovasc.Surg., 115: 310-317, 1998.

57. Herscher, L. L., Hahn, S. M., Kroog, G., Pass, H., Temeck, B., Goldspiel, B., Cook, J., Mitchell, J. B., and Liebmann, J. Phase I study of paclitaxel as a radiation sensitizer in the treatment of mesothelioma and non-small-cell lung cancer. J Clin Oncol, 16: 635-641, 1998.

58. Pass, H. I., Temeck, B. K., Kranda, K., Thomas, G., Russo, A., Smith, P., Friauf, W., and Steinberg, S. M. Phase III randomized trial of surgery with or without intraoperative photodynamic therapy and postoperative immunochemotherapy for malignant pleural mesothelioma. Ann.Surg.Oncol, 4: 628-633, 1997.

59. Mawhorter, S., Temeck, B., Chang, R., Pass, H., and Nash, T. Nonsurgical therapy for pulmonary hydatid cyst disease. Chest, 112: 1432-1436, 1997.

60. Carbone, M., Rizzo, P., and Pass, H. I. Simian virus 40, poliovaccines and human tumors: a review of recent developments. Oncogene, 15: 1877-1888, 1997.

61. Wagner, J. R., Merino, M. J., Pass, H. I., Linehan, W. M., and Walther, M. M. Pulmonary infarcts can mimic pulmonary metastases from renal cancer. J Urol., 158: 1688-1690, 1997.

62. Walther, M. M., Yang, J. C., Pass, H. I., Linehan, W. M., and Rosenberg, S. A. Cytoreductive surgery before high dose interleukin-2 based therapy in patients with metastatic renal cell carcinoma. J Urol., 158: 1675-1678, 1997.

63. De Luca, A., Baldi, A., Esposito, V., Howard, C. M., Bagella, L., Rizzo, P., Caputi, M., Pass, H. I., Giordano, G. G., Baldi, F., Carbone, M., and Giordano, A. The retinoblastoma gene family pRb/p105, p107, pRb2/p130 and simian virus-40 large T-antigen in human mesotheliomas. Nat.Med., 3: 913-916, 1997.

64. Carbone, M., Rizzo, P., Grimley, P. M., Procopio, A., Mew, D. J., Shridhar, V., de Bartolomeis, A., Esposito, V., Giuliano, M. T., Steinberg, S. M., Levine, A. S., Giordano, A., and Pass, H. I. Simian virus-40 large-T antigen binds p53 in human mesotheliomas. Nat.Med., 3: 908-912, 1997.

65. Abati, A., Sanford, J., Fetsch, P., and Pass, H. Detection of aneuploidy in mesothelioma cell lines by fluorescence in situ hybridization (FISH). Diagn.Cytopathol., 16: 375-377, 1997.

66. Pass, H. I., Kranda, K., Temeck, B. K., Feuerstein, I., and Steinberg, S. M. Surgically debulked malignant pleural mesothelioma: results and prognostic factors. Ann.Surg.Oncol, 4: 215-222, 1997.

67. Leschek, E. W., Doppman, J. L., Pass, H. I., and Cutler, G. B., Jr. Localization by venous sampling of occult chorionic gonadotropin-secreting tumor in a boy with mosaic Klinefelter's syndrome and precocious puberty. J Clin Endocrinol.Metab, 81: 3825-3828, 1996.

68. Doppman, J. L., Skarulis, M. C., Chen, C. C., Chang, R., Pass, H. I., Fraker, D. L., Alexander, H. R., Niederle, B., Marx, S. J., Norton, J. A., Wells, S. A., and Spiegel, A. M. Parathyroid adenomas in the aortopulmonary window. Radiology, 201: 456-462, 1996.

69. Temeck, B. K., Koong, S. S., Reynolds, J. C., and Pass, H. I. Somatostatin analogue in the localization and treatment of bronchial carcinoid tumours. Surg.Oncol, 5: 195-200, 1996.

70. Pompetti, F., Rizzo, P., Simon, R. M., Freidlin, B., Mew, D. J., Pass, H. I., Picci, P., Levine, A. S., and Carbone, M. Oncogene alterations in primary, recurrent, and metastatic human bone tumors. J Cell Biochem., 63: 37-50, 1996.

71. Howe, S. R., Pass, H. I., Ethier, S. P., Matthews, W. J., and Walker, C. Presence of an insulin-like growth factor I autocrine loop predicts uterine fibroid responsiveness to tamoxifen. Cancer Res., 56: 4049-4055, 1996.

72. Pass, H. I., Mew, D. J., Carbone, M., Matthews, W. A., Donington, J. S., Baserga, R., Walker, C. L., Resnicoff, M., and Steinberg, S. M. Inhibition of hamster mesothelioma tumorigenesis by an antisense expression plasmid to the insulin-like growth factor-1 receptor. Cancer Res., 56: 4044-4048, 1996.

73. Carbone, M., Rizzo, P., Procopio, A., Giuliano, M., Pass, H. I., Gebhardt, M. C., Mangham, C., Hansen, M., Malkin, D. F., Bushart, G., Pompetti, F., Picci, P., Levine, A. S., Bergsagel, J. D., and Garcea, R. L. SV40-like sequences in human bone tumors. Oncogene, 13: 527-535, 1996.

74. Temeck, B. K., Liebmann, J. E., Theodossiou, C., Steinberg, S. M., Cook, J. A., Metz, D. C., Shawker, T. H., Allegra, C. J., Russo, A., and Pass, H. I. Phase II trial of 5-fluorouracil, leucovorin, interferon-alpha-2a, and cisplatin as neoadjuvant chemotherapy for locally advanced esophageal carcinoma. Cancer, 77: 2432-2439, 1996.

75. Garza, O. T., Abati, A., Sindelar, W. F., Pass, H. I., and Hijazi, Y. M. Cytologic effects of photodynamic therapy in body fluids. Diagn.Cytopathol., 14: 356-361, 1996.

76. Pass, H. I., Mew, D. J., Kranda, K. C., Temeck, B. K., Donington, J. S., and Rosenberg, S. A. Isolated lung perfusion with tumor necrosis factor for pulmonary metastases. Ann.Thorac.Surg., 61: 1609-1617, 1996.

77. Johnson, B. E., Bridges, J. D., Sobczeck, M., Gray, J., Linnoila, R. I., Gazdar, A. F., Hankins, L., Steinberg, S. M., Edison, M., Frame, J. N., Pass, H., Nesbitt, J., Holden, D., Mulshine, J. L., Glatstein, E., and Ihde, D. C. Patients with limited-stage small-cell lung cancer treated with concurrent twice-daily chest radiotherapy and etoposide/cisplatin followed by cyclophosphamide, doxorubicin, and vincristine. J Clin Oncol, 14: 806-813, 1996.

78. Izraeli, S., Mueller, B. U., Ling, A., Temeck, B. K., Lewis, L. L., Chang, R., Shad, A. T., Pass, H. I., and Pizzo, P. A. Role of tissue diagnosis in pulmonary involvement in pediatric human immunodeficiency virus infection. Pediatr.Infect.Dis.J, 15: 112-116, 1996.

79. Shaw, G. L., Gazdar, A. F., Phelps, R., Steinberg, S. M., Linnoila, R. I., Johnson, B. E., Oie, H. K., Russell, E. K., Ghosh, B. C., Pass, H. I., Minna, J. D., Mulshine, J. L., and Ihde, D. C. Correlation of in vitro drug sensitivity testing results with response to chemotherapy and survival: comparison of non-small cell lung cancer and small cell lung cancer. J Cell Biochem.Suppl, 24: 173-185, 1996.

80. Pass, H. I. and Mew, D. J. In vitro and in vivo studies of mesothelioma. J Cell Biochem.Suppl, 24: 142-151, 1996.

81. Pass, H. I., Kennedy, R. C., and Carbone, M. Evidence for and implications of SV40-like sequences in human mesotheliomas. Important Adv.Oncol, 89-108, 1996.

82. Penno, M. B., Askin, F. B., Ma, H., Carbone, M., Vargas, M. P., and Pass, H. I. High CD44 Expression on Human Mesotheliomas Mediates Association with Hyaluronan. Cancer J Sci.Am., 1: 196, 1995.

83. Pass, H. I. and Donington, J. S. Use of photodynamic therapy for the management of pleural malignancies. Semin.Surg.Oncol, 11: 360-367, 1995.

84. Donington, J. S., Mew, D. J., and Pass, H. I. Malignant pleural mesothelioma: newer aspects of carcinogenesis, molecular genetics, and prospects for future therapies. Surg.Oncol, 4: 175-185, 1995.

85. Theodossiou, C., Temeck, B., Vargas, H., Yang, J., Vargas, M., Hahn, S., and Pass, H. Cytomegalovirus enteritis after treatment with 5-fluorouracil, leukovorin, cisplatin, and alpha-interferon. Am.J Gastroenterol., 90: 1174-1176, 1995.

86. Temeck, B. K., Wexler, L. H., Steinberg, S. M., McClure, L. L., Horowitz, M., and Pass, H. I. Metastasectomy for sarcomatous pediatric histologies: results and prognostic factors. Ann.Thorac.Surg., 59: 1385-1389, 1995.

87. Alexander, H. R., Grem, J. L., Hamilton, J. M., Pass, H. I., Hong, M., Fraker, D. L., Steinberg, S. M., McAtee, N., Allegra, C. J., and Johnston, P. G. Thymidylate Synthase Protein Expression. Cancer J Sci.Am., 1: 49, 1995.

88. Pass, H. W., Temeck, B. K., Kranda, K., Steinberg, S. M., and Pass, H. I. A phase II trial investigating primary immunochemotherapy for malignant pleural mesothelioma and the feasibility of adjuvant immunochemotherapy after maximal cytoreduction. Ann.Surg.Oncol, 2: 214-220, 1995.

89. Pass, H. I., Stevens, E. J., Oie, H., Tsokos, M. G., Abati, A. D., Fetsch, P. A., Mew, D. J., Pogrebniak, H. W., and Matthews, W. J. Characteristics of nine newly derived mesothelioma cell lines. Ann.Thorac.Surg., 59: 835-844, 1995.

90. Sekido, Y., Pass, H. I., Bader, S., Mew, D. J., Christman, M. F., Gazdar, A. F., and Minna, J. D. Neurofibromatosis type 2 (NF2) gene is somatically mutated in mesothelioma but not in lung cancer. Cancer Res., 55: 1227-1231, 1995.

91. Temeck, B. K. and Pass, H. I. Esophagopleural fistula: a complication of photodynamic therapy. South.Med.J, 88: 271-274, 1995.

92. Teruya-Feldstein, J., Temeck, B. K., Sloas, M. M., Kingma, D. W., Raffeld, M., Pass, H. I., Mueller, B., and Jaffe, E. S. Pulmonary malignant lymphoma of mucosa-associated lymphoid tissue (MALT) arising in a pediatric HIV-positive patient. Am.J Surg.Pathol., 19: 357-363, 1995.

93. Amin, K. M., Litzky, L. A., Smythe, W. R., Mooney, A. M., Morris, J. M., Mews, D. J., Pass, H. I., Kari, C., Rodeck, U., Rauscher, F. J., III, and . Wilms' tumor 1 susceptibility (WT1) gene products are selectively expressed in malignant mesothelioma. Am.J Pathol., 146: 344-356, 1995.

94. Pass, H. I., Mew, D., Pass, H. A., and Temeck, B. K. The macrophage, TNF, and other cytokines. Chest Surg.Clin N.Am., 5: 73-90, 1995.

95. Yang, J. C., Fraker, D. L., Thom, A. K., Pass, H. I., and Rosenberg, S. A. Isolation perfusion with tumor necrosis factor-alpha, interferon-gamma, and hyperthermia in the treatment of localized and metastatic cancer. Recent Results Cancer Res., 138: 161-166, 1995.

96. Shaw, G. L., Falk, R. T., Deslauriers, J., Frame, J. N., Nesbitt, J. C., Pass, H. I., Issaq, H. J., Hoover, R. N., and Tucker, M. A. Debrisoquine metabolism and lung cancer risk. Cancer Epidemiol.Biomarkers Prev., 4: 41-48, 1995.

97. Williams, K. S., Temeck, B. K., and Pass, H. I. Intrapericardial pheochromocytoma complicated by massive intraoperative hemorrhage. South.Med.J, 87: 1164-1167, 1994.

98. Moskaluk, C. A., Pogrebniak, H. W., Pass, H. I., Gallin, J. I., and Travis, W. D. Surgical pathology of the lung in chronic granulomatous disease. Am.J Clin Pathol., 102: 684-691, 1994.

99. Shilyansky, J., Wilson, W., Temeck, B. K., and Pass, H. I. Pulmonary artery-bronchial fistula during lymphoma treatment. J Thorac.Cardiovasc.Surg., 108: 790-791, 1994.

100. Pass, H. I. and Pogrebniak, H. W. Potential uses of prostaglandin E1 analog for cardiovascular disease. J Thorac.Cardiovasc.Surg., 108: 789-790, 1994.

101. Walsh, T. J., Renshaw, G., Andrews, J., Kwon-Chung, J., Cunnion, R. C., Pass, H. I., Taubenberger, J., Wilson, W., and Pizzo, P. A. Invasive zygomycosis due to Conidiobolus incongruus. Clin Infect.Dis., 19: 423-430, 1994.

102. Zeiger, M. A., Gnarra, J. R., Zbar, B., Linehan, W. M., and Pass, H. I. Loss of heterozygosity on the short arm of chromosome 3 in mesothelioma cell lines and solid tumors. Genes Chromosomes.Cancer, 11: 15-20, 1994.

103. Jensen, S. M., Jones, J. E., Pass, H., Steinberg, S. M., and Linnoila, R. I. Clara cell 10 kDa protein mRNA in normal and atypical regions of human respiratory epithelium. Int.J Cancer, 58: 629-637, 1994.

104. Temeck, B. K., Venzon, D. J., Moskaluk, C. A., and Pass, H. I. Thoracotomy for pulmonary mycoses in non-HIV-immunosuppressed patients. Ann.Thorac.Surg., 58: 333-338, 1994.

105. Pass, H. I. Contemporary approaches in the investigation and treatment of malignant pleural mesothelioma. Chest Surg.Clin N.Am., 4: 497-515, 1994.

106. Pass, H. I. 1987: Delivery of intraoperative radiation therapy after pneumonectomy: experimental observations and early clinical results. Updated in 1994. Ann.Thorac.Surg., 58: 269-270, 1994.

107. Cole, D. J., Ettinghausen, S. E., Pass, H. I., Danforth, D. N., Linehan, M. W., Myers, C. W., Cooper, M. R., and Sindelar, W. F. Postoperative complications in patients receiving suramin therapy. Surgery, 116: 90-95, 1994.

108. Walker, C., Rutten, F., Yuan, X., Pass, H., Mew, D. M., and Everitt, J. Wilms' tumor suppressor gene expression in rat and human mesothelioma. Cancer Res., 54: 3101-3106, 1994.

109. Carbone, M., Pass, H. I., Rizzo, P., Marinetti, M., Di Muzio, M., Mew, D. J., Levine, A. S., and Procopio, A. Simian virus 40-like DNA sequences in human pleural mesothelioma. Oncogene, 9: 1781-1790, 1994.

110. Pogrebniak, H. W., Witt, C. J., Terrill, R., Kranda, K., Travis, W. D., Rosenberg, S. A., and Pass, H. I. Isolated lung perfusion with tumor necrosis factor: a swine model in preparation of human trials. Ann.Thorac.Surg., 57: 1477-1483, 1994.

111. Pass, H. I. Malignant pleural mesothelioma: the thoracic surgeon and gene therapy. Ann.Thorac.Surg., 57: 1383-1384, 1994.

112. Temeck, B. K. and Pass, H. I. A method to facilitate subxiphoid pericardiotomy. Ann.Thorac.Surg., 57: 1015-1017, 1994.

113. Mulshine, J. L., Johnson, B. E., Gazdar, A. F., Shaw, G. L., Kramer, B. S., Mitsudomi, T., Minna, J. D., Pass, H., Phelps, R., Ghosh, B., and . Integrated clinical and basic studies related to circumventing non-small cell lung cancer drug resistance. Lung Cancer, 10 Suppl 1: S73-S81, 1994.

114. Dichek, H. L., Nieman, L. K., Oldfield, E. H., Pass, H. I., Malley, J. D., and Cutler, G. B., Jr. A comparison of the standard high dose dexamethasone suppression test and the overnight 8-mg dexamethasone suppression test for the differential diagnosis of adrenocorticotropin-dependent Cushing's syndrome. J Clin Endocrinol.Metab, 78: 418-422, 1994.

115. Prewitt, T. W., Matthews, W., Chaudhri, G., Pogrebniak, H. W., and Pass, H. I. Tumor necrosis factor induces doxorubicin resistance to lung cancer cells in vitro. J Thorac.Cardiovasc.Surg., 107: 43-49, 1994.

116. Tochner, Z. A., Pass, H. I., Smith, P. D., DeLaney, T. F., Sprague, M., DeLuca, A. M., Harrington, F., Thomas, G. F., Terrill, R., Bacher, J. D., and . Intrathoracic photodynamic therapy: a canine normal tissue tolerance study and early clinical experience. Lasers Surg.Med., 14: 118-123, 1994.

117. Pass, H. I., DeLaney, T. F., Tochner, Z., Smith, P. E., Temeck, B. K., Pogrebniak, H. W., Kranda, K. C., Russo, A., Friauf, W. S., Cole, J. W., and . Intrapleural photodynamic therapy: results of a phase I trial. Ann.Surg.Oncol, 1: 28-37, 1994.

118. Zeiger, M. A., Fraker, D. L., Pass, H. I., Nieman, L. K., Cutler, G. B., Jr., Chrousos, G. P., and Norton, J. A. Effective reversibility of the signs and symptoms of hypercortisolism by bilateral adrenalectomy. Surgery, 114: 1138-1143, 1993.

119. Sheppard, B. C., Temeck, B. K., Taubenberger, J. K., and Pass, H. I. Pulmonary metastatic disease in ameloblastoma. Chest, 104: 1933-1935, 1993.

120. Prewitt, T. W., Lubensky, I. A., Pogrebniak, H. W., and Pass, H. I. Orthotopic implantation of mesothelioma in the pneumonectomized immune-deficient rat: a model for innovative therapies. Int.J Cancer, 55: 877-880, 1993.

121. Shaw, G. L., Gazdar, A. F., Phelps, R., Linnoila, R. I., Ihde, D. C., Johnson, B. E., Oie, H. K., Pass, H. I., Steinberg, S. M., Ghosh, B. C., and . Individualized chemotherapy for patients with non-small cell lung cancer determined by prospective identification of neuroendocrine markers and in vitro drug sensitivity testing. Cancer Res., 53: 5181-5187, 1993.

122. Pass, H. I. and Pogrebniak, H. W. Malignant pleural mesothelioma. Curr.Probl.Surg., 30: 921-1012, 1993.

123. Walther, M. M., Alexander, R. B., Weiss, G. H., Venzon, D., Berman, A., Pass, H. I., Linehan, W. M., and Rosenberg, S. A. Cytoreductive surgery prior to interleukin-2-based therapy in patients with metastatic renal cell carcinoma. Urology, 42: 250-257, 1993.

124. Pogrebniak, H. W., Lubensky, I. A., and Pass, H. I. Differential expression of platelet derived growth factor-beta in malignant mesothelioma: a clue to future therapies? Surg.Oncol, 2: 235-240, 1993.

125. Long, J. P., Choyke, P. L., Shawker, T. A., Robertson, C. A., Pass, H. I., Walther, M. M., and Linehan, W. M. Intraoperative ultrasound in the evaluation of tumor involvement of the inferior vena cava. J Urol., 150: 13-17, 1993.

126. Broers, J. L., Viallet, J., Jensen, S. M., Pass, H., Travis, W. D., Minna, J. D., and Linnoila, R. I. Expression of c-myc in progenitor cells of the bronchopulmonary epithelium and in a large number of non-small cell lung cancers. Am.J Respir.Cell Mol.Biol., 9: 33-43, 1993.

127. Prewitt, T. W. and Pass, H. I. Photodynamic therapy for thoracic cancer: biology and applications. Semin.Thorac.Cardiovasc.Surg., 5: 229-237, 1993.

128. Alexander, H. R., Grem, J. L., Pass, H. I., Hamilton, M., McAtee, N., Fraker, D. L., and Allegra, C. J. Neoadjuvant chemotherapy for locally advanced gastric adenocarcinoma. Oncology (Huntingt), 7: 37-42, 1993.

129. Pogrebniak, H. W., Gallin, J. I., Malech, H. L., Baker, A. R., Moskaluk, C. A., Travis, W. D., and Pass, H. I. Surgical management of pulmonary infections in chronic granulomatous disease of childhood. Ann.Thorac.Surg., 55: 844-849, 1993.

130. Pass, H. I. Photodynamic therapy in oncology: mechanisms and clinical use. J Natl.Cancer Inst., 85: 443-456, 1993.

131. Pogrebniak, H. W. and Pass, H. I. Initial and reoperative pulmonary metastasectomy: indications, technique, and results. Semin.Surg.Oncol, 9: 142-149, 1993.

132. Allende, M., Pizzo, P. A., Horowitz, M., Pass, H. I., and Walsh, T. J. Pulmonary cryptococcosis presenting as metastases in children with sarcomas. Pediatr.Infect.Dis.J, 12: 240-243, 1993.

133. Pogrebniak, H. W., Matthews, W., Black, C., Russo, A., Mitchell, J. B., Smith, P., Roth, J. A., and Pass, H. I. Targetted phototherapy with sensitizer-monoclonal antibody conjugate and light. Surg.Oncol, 2: 31-42, 1993.

134. Zeiger, M. A., Pass, H. I., Doppman, J. D., Nieman, L. K., Chrousos, G. P., Cutler, G. B., Jr., Jensen, R. T., and Norton, J. A. Surgical strategy in the management of non-small cell ectopic adrenocorticotropic hormone syndrome. Surgery, 112: 994-1000, 1992.

135. Medeiros, L. J., Anasti, J., Gardner, K. L., Pass, H. I., and Nieman, L. K. Virilizing adrenal cortical neoplasm arising ectopically in the thorax. J Clin Endocrinol.Metab, 75: 1522-1525, 1992.

136. Pogrebniak, H. W., Merino, M. J., Hahn, S. M., Mitchell, J. B., and Pass, H. I. Spin trap salvage from endotoxemia: the role of cytokine down-regulation. Surgery, 112: 130-139, 1992.

137. Doppman, J. L., Pass, H. I., Nieman, L. K., Miller, D. L., Chang, R., Cutler, G. B., Jr., Chrousos, G. P., Jaffe, G. S., and Norton, J. A. Corticotropin-secreting carcinoid tumors of the thymus: diagnostic unreliability of thymic venous sampling. Radiology, 184: 71-74, 1992.

138. Pogrebniak, H. W., Haas, G., Linehan, W. M., Rosenberg, S. A., and Pass, H. I. Renal cell carcinoma: resection of solitary and multiple metastases. Ann.Thorac.Surg., 54: 33-38, 1992.

139. Pass, H. I. and Pogrebniak, H. Photodynamic therapy for thoracic malignancies. Semin.Surg.Oncol, 8: 217-225, 1992.

140. Pass, H. I., Pogrebniak, H. W., Steinberg, S. M., Mulshine, J., and Minna, J. Randomized trial of neoadjuvant therapy for lung cancer: interim analysis. Ann.Thorac.Surg., 53: 992-998, 1992.

141. Jensen, J. C., Pogrebniak, H. W., Pass, H. I., Buresh, C., Merino, M. J., Kauffman, D., Venzon, D., Langstein, H. N., and Norton, J. A. Role of tumor necrosis factor in oxygen toxicity. J Appl.Physiol, 72: 1902-1907, 1992.

142. Sherry, R. M., Pass, H. I., Rosenberg, S. A., and Yang, J. C. Surgical resection of metastatic renal cell carcinoma and melanoma after response to interleukin-2-based immunotherapy. Cancer, 69 : 1850-1855, 1992.

143. Pogrebniak, H. W., Matthews, W., and Pass, H. I. Alterations in macrophage free radical and tumor necrosis factor production by a potassium channel activator. J Surg.Res., 52: 395-400, 1992.

144. Chang, K., Pai, L. H., Pass, H., Pogrebniak, H. W., Tsao, M. S., Pastan, I., and Willingham, M. C. Monoclonal antibody K1 reacts with epithelial mesothelioma but not with lung adenocarcinoma. Am.J Surg.Pathol., 16: 259-268, 1992.

145. Broers, J. L., Jensen, S. M., Travis, W. D., Pass, H., Whitsett, J. A., Singh, G., Katyal, S. L., Gazdar, A. F., Minna, J. D., and Linnoila, R. I. Expression of surfactant associated protein-A and Clara cell 10 kilodalton mRNA in neoplastic and non-neoplastic human lung tissue as detected by in situ hybridization. Lab Invest, 66: 337-346, 1992.

146. Cook, J. A., Glass, J., Lebovics, R., Bobo, H., Pass, H., DeLaney, T. F., Oldfield, E. H., Mitchell, J. B., Glatstein, E., and Goffman, T. E. Measurement of thymidine replacement in patients with high grade gliomas, head and neck tumors, and high grade sarcomas after continuous intravenous infusions of 5-iododeoxyuridine. Cancer Res., 52: 719-725, 1992.

147. Doherty, G. M., Doppman, J. L., Miller, D. L., Gee, M. S., Marx, S. J., Spiegel, A. M., Aurbach, G. D., Pass, H. I., Brennan, M. F., and Norton, J. A. Results of a multidisciplinary strategy for management of mediastinal parathyroid adenoma as a cause of persistent primary hyperparathyroidism. Ann.Surg., 215: 101-106, 1992.

148. Feuerstein, I. M., Jicha, D. L., Pass, H. I., Chow, C. K., Chang, R., Ling, A., Hill, S. C., Dwyer, A. J., Travis, W. D., Horowitz, M. E., and . Pulmonary metastases: MR imaging with surgical correlation--a prospective study. Radiology, 182: 123-129, 1992.

149. Kenney, R. T., Kwon-Chung, K. J., Waytes, A. T., Melnick, D. A., Pass, H. I., Merino, M. J., and Gallin, J. I. Successful treatment of systemic Exophiala dermatitidis infection in a patient with chronic granulomatous disease. Clin Infect.Dis., 14: 235-242, 1992.

150. Tochner, Z. A., Pass, H. I., Sindelar, W. F., DeLuca, A. M., Grisell, D. L., Bacher, J. D., and Kinsella, T. J. Long term tolerance of thoracic organs to intraoperative radiotherapy. Int.J Radiat.Oncol Biol.Phys., 22: 65-69, 1992.

151. Pogrebniak, H. W., Prewitt, T. W., Matthews, W. A., and Pass, H. I. Tumor necrosis factor-alpha alters response of lung cancer cells to oxidative stress. J Thorac.Cardiovasc.Surg., 102: 904-907, 1991.

152. Travis, W. D., Kwon-Chung, K. J., Kleiner, D. E., Geber, A., Lawson, W., Pass, H. I., and Henderson, D. Unusual aspects of allergic bronchopulmonary fungal disease: report of two cases due to Curvularia organisms associated with allergic fungal sinusitis. Hum.Pathol., 22: 1240-1248, 1991.

153. Pass, H. I. Bronchial adenoma. Ann.Thorac.Surg., 52: 1201-1203, 1991.

154. Mitsudomi, T., Steinberg, S. M., Oie, H. K., Mulshine, J. L., Phelps, R., Viallet, J., Pass, H., Minna, J. D., and Gazdar, A. F. ras gene mutations in non-small cell lung cancers are associated with shortened survival irrespective of treatment intent. Cancer Res., 51: 4999-5002, 1991.

155. Cook, J. A., Pass, H. I., Iype, S. N., Friedman, N., DeGraff, W., Russo, A., and Mitchell, J. B. Cellular glutathione and thiol measurements from surgically resected human lung tumor and normal lung tissue. Cancer Res., 51: 4287-4294, 1991.

156. Pogrebniak, H. W., Roth, J. A., Steinberg, S. M., Rosenberg, S. A., and Pass, H. I. Reoperative pulmonary resection in patients with metastatic soft tissue sarcoma. Ann.Thorac.Surg., 52: 197-203, 1991.

157. Pogrebniak, H. W., Matthews, W., and Pass, H. I. Chemotherapy amplifies production of tumor necrosis factor. Surgery, 110: 231-237, 1991.

158. Travis, W. D., Linnoila, R. I., Tsokos, M. G., Hitchcock, C. L., Cutler, G. B., Jr., Nieman, L., Chrousos, G., Pass, H., and Doppman, J. Neuroendocrine tumors of the lung with proposed criteria for large-cell neuroendocrine carcinoma. An ultrastructural, immunohistochemical, and flow cytometric study of 35 cases. Am.J Surg.Pathol., 15: 529-553, 1991.

159. Pogrebniak, H., Matthews, W., Mitchell, J., Russo, A., Samuni, A., and Pass, H. Spin trap protection from tumor necrosis factor cytotoxicity. J Surg.Res., 50: 469-474, 1991.

160. Jensen, J. C., Choyke, P. L., Rosenfeld, M., Pass, H. I., Keiser, H., White, B., Travis, W., and Linehan, W. M. A report of familial carotid body tumors and multiple extra-adrenal pheochromocytomas. J Urol., 145: 1040-1042, 1991.

161. Pass, H. I., Evans, S., Matthews, W. A., Perry, R., Venzon, D., Roth, J. A., and Smith, P. Photodynamic therapy of oncogene-transformed cells. J Thorac.Cardiovasc.Surg., 101: 795-799, 1991.

162. Travis, W. D., Hoffman, G. S., Leavitt, R. Y., Pass, H. I., and Fauci, A. S. Surgical pathology of the lung in Wegener's granulomatosis. Review of 87 open lung biopsies from 67 patients. Am.J Surg.Pathol., 15: 315-333, 1991.

163. Jensen, J. C., Pass, H. I., Sindelar, W. F., and Norton, J. A. Recurrent or metastatic disease in select patients with adrenocortical carcinoma. Aggressive resection vs chemotherapy. Arch.Surg., 126: 457-461, 1991.

164. Perry, R. R., Smith, P. D., Evans, S., and Pass, H. I. Intravenous vs intraperitoneal sensitizer: implications for intraperitoneal photodynamic therapy. Photochem.Photobiol., 53: 335-340, 1991.

165. Doppman, J. L., Pass, H. I., Nieman, L. K., Findling, J. W., Dwyer, A. J., Feuerstein, I. M., Ling, A., Travis, W. D., Cutler, G. B., Jr., Chrousos, G. P., and . Detection of ACTH-producing bronchial carcinoid tumors: MR imaging vs CT. AJR Am.J Roentgenol., 156: 39-43, 1991.

166. Pass, H. I. Symposium on thoracic surgical oncology. Ann.Thorac.Surg., 51: 163, 1991.

167. Perry, R. R., Keiser, H. R., Norton, J. A., Wall, R. T., Robertson, C. N., Travis, W., Pass, H. I., Walther, M. M., and Linehan, W. M. Surgical management of pheochromocytoma with the use of metyrosine. Ann.Surg., 212: 621-628, 1990.

168. Pass, H. I., Tochner, Z., DeLaney, T., Smith, P., Friauf, W., Glatstein, E., and Travis, W. Intraoperative photodynamic therapy for malignant mesothelioma. Ann.Thorac.Surg., 50: 687-688, 1990.

169. Wall, R. T., Buzzanell, C. A., Epstein, T. A., Malech, H. L., Melnick, D., Pass, H. I., and Gallin, J. I. Anesthetic considerations in patients with chronic granulomatous disease. J Clin Anesth., 2: 306-311, 1990.

170. Robertson, C. N., Linehan, W. M., Pass, H. I., Gomella, L. G., Haas, G. P., Berman, A., Merino, M., and Rosenberg, S. A. Preparative cytoreductive surgery in patients with metastatic renal cell carcinoma treated with adoptive immunotherapy with interleukin-2 or interleukin-2 plus lymphokine activated killer cells. J Urol., 144: 614-617, 1990.

171. Perry, R. R., Matthews, W., Mitchell, J. B., Russo, A., Evans, S., and Pass, H. I. Sensitivity of different human lung cancer histologies to photodynamic therapy. Cancer Res., 50: 4272-4276, 1990.

172. Travis, W. D., Pittaluga, S., Lipschik, G. Y., Ognibene, F. P., Suffredini, A. F., Masur, H., Feuerstein, I., Kovacs, J., Pass, H. I., Condron, K. S., and . Atypical pathologic manifestations of Pneumocystis carinii pneumonia in the acquired immune deficiency syndrome. Review of 123 lung biopsies from 76 patients with emphasis on cysts, vascular invasion, vasculitis, and granulomas. Am.J Surg.Pathol., 14: 615-625, 1990.

173. Pass, H. I., Doppman, J. L., Nieman, L., Stovroff, M., Vetto, J., Norton, J. A., Travis, W., Chrousos, G. P., Oldfield, E. H., and Cutler, G. B., Jr. Management of the ectopic ACTH syndrome due to thoracic carcinoids. Ann.Thorac.Surg., 50: 52-57, 1990.

174. Perry, R. R., Venzon, D., Roth, J. A., and Pass, H. I. Survival after surgical resection for high-grade chest wall sarcomas. Ann.Thorac.Surg., 49: 363-368, 1990.

175. Feurestein, I. M., Archer, A., Pluda, J. M., Francis, P. S., Falloon, J., Masur, H., Pass, H. I., and Travis, W. D. Thin-walled cavities, cysts, and pneumothorax in Pneumocystis carinii pneumonia: further observations with histopathologic correlation. Radiology, 174: 697-702, 1990.

176. Evans, S., Matthews, W., Perry, R., Fraker, D., Norton, J., and Pass, H. I. Effect of photodynamic therapy on tumor necrosis factor production by murine macrophages. J Natl.Cancer Inst., 82: 34-39, 1990.

177. Pass, H. I. and Reed, C. E. Lasers in the management of upper aerodigestive malignancies. Important Adv.Oncol, 159-179, 1990.

178. Doppman, J. L., Pass, H. I., Nieman, L., Cutler, G. B., Jr., Chrousos, G. P., and Loriaux, D. L. Failure of bronchial lavage to detect elevated levels of adrenocorticotropin (ACTH) in patients with ACTH-producing bronchial carcinoids. J Clin Endocrinol.Metab, 69: 1302-1304, 1989.

179. Takahashi, T., Nau, M. M., Chiba, I., Birrer, M. J., Rosenberg, R. K., Vinocour, M., Levitt, M., Pass, H., Gazdar, A. F., and Minna, J. D. p53: a frequent target for genetic abnormalities in lung cancer. Science, 246: 491-494, 1989.

180. Horan, J. J., Robertson, C. N., Choyke, P. L., Frank, J. A., Miller, D. L., Pass, H. I., and Linehan, W. M. The detection of renal carcinoma extension into the renal vein and inferior vena cava: a prospective comparison of venacavography and magnetic resonance imaging. J Urol., 142: 943-947, 1989.

181. Matthews, W., Rizzoni, W., Mitchell, J., Russo, A., and Pass, H. In vitro photodynamic therapy of human lung cancer. J Surg.Res., 47: 276-281, 1989.

182. Doppman, J. L., Nieman, L., Miller, D. L., Pass, H. I., Chang, R., Cutler, G. B., Jr., Schaaf, M., Chrousos, G. P., Norton, J. A., Ziessman, H. A., and . Ectopic adrenocorticotropic hormone syndrome: localization studies in 28 patients. Radiology, 172: 115-124, 1989.

183. Perry, R. R., Rosenberg, R. K., and Pass, H. I. Tracheoesophageal fistula in the patient with lymphoma: case report and review of the literature. Surgery, 105: 770-777, 1989.

184. Rosengart, T. K., Pass, H., Cannon, R., Miller, D. L., Solomon, D., and Clark, R. E. Ruptured gastroepiploic artery aneurysm and vascular collapse in a patient with thoracic aneurysm. J Cardiovasc.Surg.(Torino), 30: 514-516, 1989.

185. Cook, J. A., Pass, H. I., Russo, A., Iype, S., and Mitchell, J. B. Use of monochlorobimane for glutathione measurements in hamster and human tumor cell lines. Int.J Radiat.Oncol Biol.Phys., 16 : 1321-1324, 1989.

186. Jablons, D., Steinberg, S. M., Roth, J., Pittaluga, S., Rosenberg, S. A., and Pass, H. I. Metastasectomy for soft tissue sarcoma. Further evidence for efficacy and prognostic indicators. J Thorac.Cardiovasc.Surg., 97: 695-705, 1989.

187. Pass, H. I., DeLaney, T., Smith, P. D., Bonner, R., and Russo, A. Bronchoscopic phototherapy at comparable dose rates: early results. Ann.Thorac.Surg., 47: 693-699, 1989.

188. Perry, R. R., Evans, S., Matthews, W., Rizzoni, W., Russo, A., and Pass, H. I. Potentiation of phototherapy cytotoxicity with light scattering media. J Surg.Res., 46: 386-390, 1989.

189. Matthews, W., Cook, J., Mitchell, J. B., Perry, R. R., Evans, S., and Pass, H. I. In vitro photodynamic therapy of human lung cancer: investigation of dose-rate effects. Cancer Res., 49: 1718-1721, 1989.

190. Rex, J. H., Ginsberg, A. M., Fries, L. F., Pass, H. I., and Kwon-Chung, K. J. Cunninghamella bertholletiae infection associated with deferoxamine therapy. Rev.Infect.Dis., 10: 1187-1194, 1988.

191. Lefor, A. T., Merino, M. M., Steinberg, S. M., Dwyer, A., Roth, J. A., Flanagan, M., and Pass, H. I. Computerized tomographic prediction of extraluminal spread and prognostic implications of lesion width in esophageal carcinoma. Cancer, 62: 1287-1292, 1988.

192. Sindelar, W. F., Hoekstra, H. J., Kinsella, T. J., Barnes, M., DeLuca, A. M., Tochner, Z., Pass, H. I., Kranda, K. C., and Terrill, R. E. Response of canine esophagus to intraoperative electron beam radiotherapy. Int.J Radiat.Oncol Biol.Phys., 15: 663-669, 1988.

193. Travis, W. D., Linnoila, R. I., Horowitz, M., Becker, R. L., Jr., Pass, H., Ozols, R., and Gazdar, A. Pulmonary nodules resembling bronchioloalveolar carcinoma in adolescent cancer patients. Mod.Pathol., 1: 372-377, 1988.

194. Roth, J. A., Pass, H. I., Flanagan, M. M., Graeber, G. M., Rosenberg, J. C., and Steinberg, S. Randomized clinical trial of preoperative and postoperative adjuvant chemotherapy with cisplatin, vindesine, and bleomycin for carcinoma of the esophagus. J Thorac.Cardiovasc.Surg., 96: 242-248, 1988.

195. Pogrebniak, H. W., Stovroff, M., Roth, J. A., and Pass, H. I. Resection of pulmonary metastases from malignant melanoma: results of a 16-year experience. Ann.Thorac.Surg., 46: 20-23, 1988.

196. Perry, R. R., Knego, R. S., and Pass, H. I. Trachea-innominate artery fistula. J Thorac.Cardiovasc.Surg., 96: 184-185, 1988.

197. Ognibene, F. P., Pass, H. I., Roth, J. A., Shelhamer, J. H., and Milne, E. N. Role of imaging and interventional techniques in the diagnosis of respiratory disease in the immunocompromised host. J Thorac.Imaging, 3: 1-20, 1988.

198. Wiebke, E. A., McDonald, H. D., and Pass, H. I. The infected chest wall prosthesis: management by excision and contralateral transverse rectus abdominis musculocutaneous flap. Ann.Thorac.Surg., 44: 544-545, 1987.

199. Lanza, L. A., Miser, J. S., Pass, H. I., and Roth, J. A. The role of resection in the treatment of pulmonary metastases from Ewing's sarcoma. J Thorac.Cardiovasc.Surg., 94: 181-187, 1987.

200. Pass, H. I., Sindelar, W. F., Kinsella, T. J., DeLuca, A. M., Barnes, M., Kurtzman, S., Hoekstra, H., Tochner, Z., Roth, J., and Glatstein, E. Delivery of intraoperative radiation therapy after pneumonectomy: experimental observations and early clinical results. Ann.Thorac.Surg., 44: 14-20, 1987.

201. Doppman, J. L., Loughlin, T., Miller, D. L., Pass, H. I., Chrousos, G. P., Cutler, G. B., Oldfield, E. H., and Loriaux, D. L. Identification of ACTH-producing intrathoracic tumors by measuring ACTH levels in aspirated specimens. Radiology, 163: 501-503, 1987.

202. Wall, R. T., Pass, H. I., and McDonald, H. D. Unusual presentation and novel solution for hemodynamic compromise during thoracic surgery. Anesthesiology, 66: 566-568, 1987.

203. Barnes, M., Pass, H., DeLuca, A., Tochner, Z., Potter, D., Terrill, R., Sindelar, W. F., and Kinsella, T. J. Response of the mediastinal and thoracic viscera of the dog to intraoperative radiation therapy (IORT). Int.J Radiat.Oncol Biol.Phys., 13: 371-378, 1987.

204. Rizzoni, W. E., Pass, H. I., Wesley, M. N., Rosenberg, S. A., and Roth, J. A. Resection of recurrent pulmonary metastases in patients with soft-tissue sarcomas. Arch.Surg., 121: 1248-1252, 1986.

205. Edington, H., Salwitz, J., Longo, D. L., Roth, J. A., and Pass, H. Thymic hyperplasia masquerading as recurrent Hodgkin's disease: case report and review of the literature. J Surg.Oncol, 33: 120-123, 1986.

206. Roth, J. A., Pass, H. I., Wesley, M. N., White, D., Putnam, J. B., and Seipp, C. Comparison of median sternotomy and thoracotomy for resection of pulmonary metastases in patients with adult soft-tissue sarcomas. Ann.Thorac.Surg., 42: 134-138, 1986.

207. Udelsman, R., Roth, J. A., Lees, D., Jelenich, S. E., and Pass, H. I. Endobronchial metastases from soft tissue sarcoma. J Surg.Oncol, 32: 145-149, 1986.

208. Pass, H. I., Potter, D., Shelhammer, J., Macher, A., Ognibene, F. P., Longo, D. L., Gelmann, E., Masur, H., and Roth, J. A. Indications for and diagnostic efficacy of open-lung biopsy in the patient with acquired immunodeficiency syndrome (AIDS). Ann.Thorac.Surg., 41: 307-312, 1986.

209. Potter, D., Pass, H. I., Brower, S., Macher, A., Browne, M., Thaler, M., Cotton, D., Hathorn, J., Wesley, R., Longo, D., and . Prospective randomized study of open lung biopsy versus empirical antibiotic therapy for acute pneumonitis in nonneutropenic cancer patients. Ann.Thorac.Surg., 40: 422-428, 1985.

210. Pass, H. I. and Roth, J. A. Treatment of chylothorax. J Thorac.Cardiovasc.Surg., 90: 451-452, 1985.

211. Pass, H. I., Dwyer, A., Makuch, R., and Roth, J. A. Detection of pulmonary metastases in patients with osteogenic and soft-tissue sarcomas: the superiority of CT scans compared with conventional linear tomograms using dynamic analysis. J Clin Oncol, 3: 1261-1265, 1985.

212. Ognibene, F. P., Steis, R. G., Macher, A. M., Liotta, L., Gelmann, E., Pass, H. I., Lane, H. C., Fauci, A. S., Parrillo, J. E., Masur, H., and . Kaposi's sarcoma causing pulmonary infiltrates and respiratory failure in the acquired immunodeficiency syndrome. Ann.Intern.Med., 102: 471-475, 1985.

213. Pass, H. I., Potter, D. A., Macher, A. M., Reichert, C., Shelhammer, J. H., Masur, H., Ognibene, F., Gelmann, E., Lane, H. C., Fauci, A., and . Thoracic manifestations of the acquired immune deficiency syndrome. J Thorac.Cardiovasc.Surg., 88: 654-658, 1984.

214. Pass, H. I., Sade, R. M., Crawford, F. A., and Hohn, A. R. Cardiac valve prostheses in children without anticoagulation. J Thorac.Cardiovasc.Surg., 87: 832-835, 1984.

215. Gobien, R. P., Stanley, J. H., Gobien, B. S., Vujic, I., and Pass, H. I. Percutaneous catheter aspiration and drainage of suspected mediastinal abscesses. Radiology, 151: 69-71, 1984.

216. Pass, H. I., Crawford, F. A., Jr., Sade, R. M., Assey, M. E., and Usher, B. W. Congenital heart disease in adults. Am.Surg., 50: 36-39, 1984.

217. Warren, E. T., Pass, H. I., and Crawford, F. A., Jr. External cardiopulmonary resuscitation augmented by the military antishock trousers. Am.Surg., 49: 651-654, 1983.

218. Pass, H. I., Turner, M. D., Neely, W. A., and Crawford, F. A., Jr. Nitroprusside-epinephrine administration in acute myocardial ischemia. World J Surg., 7: 773-779, 1983.

219. Pass, H. I. and Crawford, F. A., Jr. Radioactive microspheres: a useful tool in the investigation of myocardial ischemia. J S.C.Med.Assoc., 79: 259-263, 1983.

220. Byrne, D., Pass, H. I., Neely, W. A., Turner, M. D., and Crawford, F. A., Jr. External versus internal cardiac massage in normal and chronically ischemic dogs. Am.Surg., 46: 657-662, 1980.

221. Byrne, D. E., Pass, H. I., and Crawford, F. A., Jr. Traumatic vena caval injuries. Am.J Surg., 140: 600-602, 1980.

222. Didlake, R. H., Pass, H. I., and Raju, S. Colon obstruction secondary to adhesive splenomegaly: a case report. J Miss.State Med.Assoc., 21: 237-239, 1980.

223. Kaskey, G. B., Salzman, L. F., Klorman, R., and Pass, H. L. Relationships between stimulus intensity and amplitude of visual and auditory event related potentials. Biol.Psychol., 10: 115-125, 1980.

224. Pass, H. L., Klorman, R., Salzman, L. F., Klein, R. H., and Kaskey, G. B. The late positive component of the evoked response in acute schizophrenics during a test of sustained attention. Biol.Psychiatry, 15: 9-20, 1980.

225. Podolnick, E. E., Pass, H. L., and Bybee, D. M. A psychodynamic approach to brief therapy. J Am.Coll.Health Assoc., 28: 109-113, 1979.

226. Klorman, R., Salzman, L. F., Pass, H. L., Borgstedt, A. D., and Dainer, K. B. Effects of methylphenidate on hyperactive children's evoked responses during passive and active attention. Psychophysiology, 16: 23-29, 1979.

227. Hagan, J. L., Pass, H. I., Turner, M. D., Neely, W. A., and Hardy, J. D. Development of collateral blood flow in canine adrenal autotransplants. Surg.Forum, 30: 318-319, 1979.

228. Yee, H. W., Pass, H. I., Turner, M. D., Neely, W. A., and Crawford, F. A., Jr. Nitroprusside-epinephrine therapy in experimental cardiogenic shock. Surg.Forum, 30: 24-25, 1979.

229. Pass, H. L., Salzman, L. F., Klorman, R., Kaskey, G. B., and Klein, R. H. The effect of distraction on acute schizophrenics' visual tracking. Biol.Psychiatry, 13: 587-593, 1978.

230. Cox, J. L., Helfrich, L. R., Pass, H. I., Osterhaut, S., and Shingleton, W. W. The relationship between biliary tract infections and postoperative complications. Surg.Gynecol.Obstet., 146: 233-236, 1978.

231. Pass, H. I., Turner, M. D., Neely, W. A., and Crawford, F. A., Jr. Nitroprusside-epinephrine therapy in acute myocardial ischemia. Surg.Forum, 29: 310-312, 1978.

232. Cox, J. L., Anderson, R. W., Pass, H. I., Currie, W. D., Roe, C. R., Mikat, E., Wechsler, A. S., and Sabiston, D. C., Jr. The safety of induced ventricular fibrillation during cardiopulmonary bypass in nonhypertrophied hearts. J Thorac.Cardiovasc.Surg., 74: 423-432, 1977.

233. Cox, J. L., Pass, H. I., Oldham, H. N., Jr., Wechsler, A. S., and Sabiston, D. C., Jr. Coronary collateral circulation during stress and the effects of aorta-coronary bypass grafts. J Thorac.Cardiovasc.Surg., 71: 540-544, 1976.

234. Cox, J. L., Pass, H. I., Anderson, R. W., Wechsler, A. S., Oldham, H. N., Jr., and Sabiston, D. C. Augmentation of coronary collateral blood flow in acute myocardial infarction. Surg.Forum, 26 : 238-240, 1975.

235. Cox, J. L., Pass, H. I., Wechsler, A. S., Oldham, H. N., Jr., and Sabiston, D. C., Jr. Coronary collateral blood flow in acute myocardial infarction. J Thorac.Cardiovasc.Surg., 69: 117-125, 1975.

236. Oldham, H. N., Jr., Cox, J. L., Pass, H. I., Wechsler, A. S., and Sabiston, D. C., Jr. Effects of pulmonary embolism on regional myocardial blood flow. Surgery, 76: 160-169, 1974.

237. Cox, J. L., Pass, H. I., Wechsler, A. S., Oldham, H. N., Jr., and Sabiston, D. C., Jr. Evolution and transmural distribution of collateral blood flow in acute myocardial infarction. Surg.Forum, 24: 154-156, 1973.

Books and Chapters

Text Books

1. Surgery, Basic Principles and Practice. Hardy, J.D., Editor; Kukora, J., and Pass, H.I., Editorial Assistants. J. B. Lippincott Co.,Philadelphia, l982.

2. Surgery, Basic Principles and Practice, 2nd edition. Hardy JD, editor, Kukora J and Pass HI, assistant editors, J.B. Lippincott Co., Philadelphia, 1988.

3. Lung Cancer: Principles and Practice. Pass, H.I., Mitchell, J.B., Johnson, D., and Turissi, A. (eds). J.B. Lippincott, Co., Philadelphia, PA, 1996.

4. Lung Cancer: Principles and Practice, Second Edition. Pass, H.I., Mitchell, J.B., Johnson, D., Turissi, A., and Minna (eds). J.B. Lippincott, Co., Philadelphia, PA, 2000.

5. Surgery: Scientific Basis and Current Practice. Norton J, Bollinger R, Chang F, Lowry S, Mulvihill S, Pass H, and Thompson R (eds). Springer Verlag. New York, NY, 2000.

6. Essential Practice of Surgery: Basic Science and Clinical Evidence. Norton J, Bollinger R, Chang F, Lowry S, Mulvihill S, Pass H, and Thompson R (eds). Springer Verlag. New York, NY, 2003.

7. Lung Cancer: Principles and Practice, Third Edition. Pass, H.I., Johnson, D., Turissi, A., Carbone, D., and Minna (eds). J.B. Lippincott, Co., Philadelphia, PA, due 2004.

8. Malignant Mesothelioma: Advances in Pathogenesis, Diagnosis, and Translational Therapies. Pass H., Vogelzang N, and Carbone M. Springer Verlag. New York, NY, due 2003

Chapters

1.Pass, H.I.: Intravenous Alimentation in Critical Surgical Illness. James D. Hardy, ed., W.B. Saunders Co., l980.

2.Pass, H.I., and Hardy, J.D.: The Gallbladder and Acute Cholecystitis in General Surgery Principles in Practice. Robert Zollinger, ed.,Le Jacq Publishing Co., l98l.

3.Pass, H.I., and Hardy, J.D.: Surgical Lesions of the Common Bile Duct in General Surgery Principles in Practice. Robert Zollinger, ed.,Le Jacq Publishing Co., l98l.

4.Pass, H.I., and Hardy, J.D.: Liver Trauma and Liver Abscess in General Surgery Principles in Practice. Robert Zollinger, ed., Le Jacq Publishing Co., l98l.

5.Pass, H.I., and Hardy, J.D.: Liver Tumors in General Surgery Principles in Practice. Robert Zollinger, ed., Le Jacq Publishing Co., l98l.

6.Pass, H.I., and Sade, R.M.: Tracheo-Esophageal Compressive Syndromes of Vascular Origins: Rings and Slings in Thoracic and Cardiovascular Surgery. William W.L. Glenn, ed., Appleton-Century-Crofts, l982.

7.Pass, H.I., and Hardy, J.D.: Appendicitis and Intra-Abdominal Abscess in Surgery, Basic Principles and Practice. James D. Hardy, ed., J.B. Lippincott Co., l982.

8.Pass, H.I.: Supportive Conditions of the Lung, Tuberculosis, and Fungus Diseases in Surgery, Basic Principles and Practice. James D. Hardy, ed., J.B. Lippincott Co., l982.

9.Shelhammer, J., Ognibene, F., Roth, J.A., Pass, H.I.: Pulmonary Complications of the Acquired Immune Deficiency Syndrome in Critical Care of the Immunosuppressed Host. Parillo, J., ed., ASPEN Press, 1987.

10. Pass, H.I., and Roth, J.: The Diagnosis of Pulmonary Metastases in Surgical Management of Metastatic Disease. Steven A. Rosenberg, ed., Lippincott, 1987.

11. Kern, K., Pass, H., and Roth, J: The Surgical Management of Pulmonary Metastases, in Surgical Management of Metastatic Disease. Steven A. Rosenberg, ed., Lippincott, 1987.

12. Roth JA, Pass HI, Flanagan MM, et al: Clinical trials with Cisplatin, Vindisine, and Bleomycin: Neoadjuvant Chemotherapy for Epidermoid Carcinoma of the Esophagus. In Gastrointestinal Cancer: Current Approaches to Diagnosis and Treatment. Levin, B. ed., University of Texas Press, 1988.

13. Pass HI, and Hardy JD.: Appendicitis and Intra-Abdominal Abscess in Surgery, Basic Principles and Practice, 2nd edition. James D. Hardy, ed., J.B. Lippincott Co., 1988.

14. Pass, HI: Supportive Conditions of the Lung, Tuberculosis, and Fungus Diseases in Surgery, Basic Principles and Practice, 2nd edition.

15. James D. Hardy, ed., J.B. Lippincott Co., 1988.

16. Pass HI: Chest Wall and Pleura in Surgery, Basic Principles and Practice, 2nd edition. James D. Hardy, ed. J.B. Lippincott Co., 1988.

17. Pass, H.I.: Chest Wall Tumors, in Textbook of Thoracic Oncology.

18. J. Roth, ed., Saunders, Philadelphia, PA. 1988.

19. Pass, H.I.: Carcinoma of the Esophagus: Clinical Presentation and Stricture Management in Textbook of Thoracic Oncology. J. Roth, ed., Saunders, Philadelphia, PA. 1988

20. Pass HI: Malignant Pleural and Pericardial Effusions, in Cancer: Principles and Practice of Oncology. Third Edition. DeVita, Hellman, and Rosenberg, eds., Lippincott, Philadelphia, PA. 1989.

21.Antman K, and Pass HI: Mesothelioma, in Cancer: Principles and Practice of Oncology. Third Edition. DeVita, Hellman, and Rosenberg, eds. Lippincott, Philadelphia, PA.1989.

22. Minna J, Ihde D, Pass HI, and Glatstein E: Lung Cancer in Cancer: Principles and Practice of Oncology. Third Edition. DeVita, Hellman, and Rosenberg, eds., Lippincott, Philadelphia, PA. 1989.

23. Russo A, Mitchell J, Pass HI, and Glatstein E: Photodynamic Therapy in Cancer: Principles and Practice of Oncology. Third Edition. Devita, Hellman, and Rosenberg, eds. Lippincott, Philadelphia, PA 1989.

24. Pass HI and Reed C: Lasers in the Management of Malignant Aerodigestive Disease. In Important Advances in Oncology DeVita, Hellman, and Rosenberg (eds) Lippincott,Philadelphia, PA. 1990.

25. Delaney TF, Sindelar W, Smith P, Friauf W, Pass H, Russo A, Thomas G, Dachowski L. Cole J and Glatstein E. Initial experience with photodynamic therapy for intraperitoneal carcinomatosis. In: Ovarian Cancer. Sharp, Leake, Mason (eds). London: Chapman and Hall, 1990.

26. Pass H and Delaney T: Innovative Photodynamic Therapy at the National Cancer Institute in Photodynamic Therapy: Basic Principles and Clinical Aspects. Henderson B and Dougherty T, eds. Marcel Dekker, Ch.19; 287-301, 1992.

27. Antman K, Pass H, Delaney T: Mesothelioma in Cancer: Principles and Practice of Oncology. Fourth Edition. DeVita, Hellman and Rosenberg, eds., Lippincott, Philadelphia, PA. l993.

28. Pass H, Delaney T: Photodynamic therapy in Cancer: Principles and Practice of Oncology. Fourth Edition. DeVita, Hellman and Rosenberg, eds., Lippincott,Philadelphia, PA. l993.

29. Ihde D, Pass H, Glatstein E: Small cell lung carcinoma in Cancer: Principles and Practices of Oncology. Fourth Edition. Devita, Hellman and Rosenberg, eds., Lippincott, Philadelphia, PA.l993.

30. Pass H: Management of metastatic disease to the lungs in Cancer: Principles and Practice of Oncology. Fourth Edition. DeVita, Hellman, Rosenberg (eds.)., Lippincott, Philadelphia, PA. l993.

31. Pass H: Pleural and pericardial effusions in Cancer: Principles and Practice of Oncology. Fourth Edition. DeVita, Hellman, Rosenberg (eds.), Lippincott, Philadelphia, PA. l993.

32. Prewitt T, Pass H: Photodynamic Therapy in Advances in the diagnosis and therapy of lung cancer. Roth JA (ed.),, Blackwell, l993.

33. Pogrebniak HW, Pass HI: Biologic Therapy of Lung Cancer in Thoracic Surgery, Volume One. Pearson, DesLauriers, Ginsberg (eds.), Churchill Livingstone, l995.

34. Friauf, W.S., Smith, P.E., Russo, A., DeLaney, T.F., Pass, H.I., Cole, J.W., Gibson, C.C., Sindelar, W.F., Thomas,G. Light monitoring in photo-dynamic therapy in Case Studies in Medical Instrument Design. Nagle HT and Tompkins WJ, eds. The Institute of Electrical and Electronics Engineers Inc, New York. 1994.

35. Pass, H.I., Alexander, H.R., Fraker, D.L. Biologic therapy with TNF: Clinical applications: Isolation perfusion, in: Biologic Therapy of Cancer, DeVita, V., Hellman, S., Rosenberg, S.A., eds. 2nd ed. J.B. Lippincott, Philadelphia. 1994

36. Pass, H.I. Chest Wall Neoplasms. In. Thoracic Oncology, Roth J (ed), Saunders, Philadelphia, PA. (1995).

37. Pass, H.I., Temeck, B.T. Intrathoracic Metastases, In: Comprehensive Textbook of Thoracic Oncology. Williams & Wilkins, Baltimore, Md. (1996).

38. Temeck, B. and Pass, H.I. Surgical treatment of mesothelioma. In: Sourcebook on Asbestos Diseases. Peters, G. and Peters, B. (eds). Butterworth Publishers, New York (1996).

39. Pass, H.A. and Pass, H.I. Biologic therapy of lung cancer.In: Lung Cancer: Principles and Practice. Pass, H.I., Mitchell, J.B., Johnson, D., Turissi (eds). J.B. Lippincott, Co., Philadelphia (1995)

40. Pass, H.I. and Temeck, B. Superior sulcus tumors. In: Lung Cancer: Principles and Practice. Pass, H.I., Mitchell, J.B., Johnson, D., Turissi (eds). J.B. Lippincott, Co., Philadelphia (1995)

41. Johnson, D., Turissi, A., Pass, H.I. Multimodality therapy of lung cancer. In: Lung Cancer: Principles and Practice. Pass, H.I., Mitchell, J.B., Johnson, D., Turissi, A. (eds). J. B. Lippincott, Co., Philadelphia (1995).

42. Pass, H.I. Mesothelioma. In: Follow-up of Cancer: A Handbook for Physicians. Fischer, D.S. (ed). J.B. Lippincott, Co., Philadelphia. (1995).

43. Chen, P. and Pass, H.I. Indications for resection of pulmonary metastases. In: Thoracic and Cardiovascular. Baue, A., Laks, H., Naunheim,R. (eds). Appleton-Century-Crofts, Philadelphia (1995).

44. Pass, HI. Isolated lung perfusion for pulmonary metastases. In: Regional Therapy of Cancer. Lotze, M.T. and Rubin, J.T. (eds). J.B. Lippincott, Co. Philadelphia pp 63-74.

45. Bright RK and Pass HI: Tumor Immunity and Vaccination Against Viral Induced Tumors for Sourcebook on Asbestos Disease, Peters G, ed, Peters and Peters, Santa Monica, California .

46. Pass HI: Photodynamic Therapy and Thoracic Malignancies for Lung Cancer, Second Edition, Roth J, ed, Blackwell Science, Malden MA

47. Pass HI: Photodynamic Therapy and Thoracic Malignancies for Advanced Therapy in Thoracic Surgery, Putnam J and Franco E, eds. B.C.Decker Inc, New York

48. Carbone, M., Rizzo, P., and Pass, H. Association of simian virus 40 with rodent and human mesothelioma. In: DNA Tumor Viruses: Oncogenic Mechanisms. Barbanti-Brodano and Friedman (eds). Plenum Press, New York..

49. Pass, H.I., Carbone, M. and Kennedy, R. DNA Virus-Like Particles and Mesothelioma. In: Important Advances in Oncology. DeVita, V., Hellman, S., Rosenberg, S. (eds). J.B. Lippincott, Co., Philadelphia. (1996), pp 89-110.

50. Antman K, Pass H, Schiff, P: Mesothelioma in Cancer: Principles and Practice of Oncology. Fifth Edition. DeVita, Hellman and Rosenberg, eds., Lippincott,Philadelphia (1997), pp1853-1879

51. Ihde D, Pass H, Glatstein E: Small cell lung carcinoma in Cancer: Principles and Practices of Oncology. Fifth Edition Devita, Hellman and Rosenberg, eds., Lippincott, Philadelphia 1997, pp. 911-950.

52. Pass H and Donington J: Management of metastatic disease to the lungs in Cancer: Principles and Practice of Oncology. Fifth Edition. DeVita, Hellman, Rosenberg (eds.)., Lippincott, Philadelphia, PA, 1997, pp 2536-2551

53. Pass H: Pleural and pericardial effusions in Cancer: Principles and Practice of Oncology. Fifth Edition. DeVita, Hellman, Rosenberg (eds.), Lippincott,Philadelphia 1997, pp. 2586-2597.

54. Pass H and Donington J: Management of metastatic disease to the lungs in Cancer: Principles and Practice of Oncology. Fifth Edition. DeVita, Hellman, Rosenberg (eds.)., Lippincott, Philadelphia, PA, 1997, pp 2536-2551

55. Shearer MH, Pass H, Carbone M, and Kennedy R: Modulation of the immune response to simian virus 40 large tumor antigen via idiotype-anti-idiotype interactions in Idiotypes in Medicine: Infections, Autoimmunity, and Cancer. Schoenfeld Y (ed). Elsevier, NY 1998

56. Mew DJY, Donington J, and Pass H: Diagnosis of Pulmonary Metastatic Disease. In: Regional Therapy of Cancer. Lotze, M.T. and Rubin, J.T. (eds). J.B. Lippincott, Co. Philadelphia, pp 23-36.

57. Carbone, M., Powers, A., Pass, H., Fisher, S., Di Resta, I., Mutti, L., Kast, W. M., and Rizzo, P. Asbestos, Simian Virus 40, and the Development of Malignant Mesothelioma. Sourcebook on Asbestos Diseases, Volume 18, pp. 269-287. Santa Monica, Calif: Lexis Law Pubishing, 1999

58. Pass H and Kalemkerian: Molecular Biology and Pathology of Lung Cancer. In: Shields General Thoracic Surgery. Shields T, and LoCicero J, eds. Lippincott Williams and Wilkens, Philadelphia, PA 2000.

59. Chahininan P and Pass H: Malignant Mesothelioma. In: Cancer Medicine, Edition 5, Bast, Kufe, Pollock, Weicheselbaum, Holland, Frei.

60. Antman K, Pass H, Schiff, P: Mesothelioma in Cancer: Principles and Practice of Oncology. Sixth Edition. DeVita, Hellman and Rosenberg, eds., Lippincott,Philadelphia (2000),

61. Murran J, Pass H, Glatstein E: Small cell lung carcinoma in Cancer: Principles and Practices of Oncology. Fifth Edition Devita, Hellman and Rosenberg, eds., Lippincott, Philadelphia (2000).

62. Carbone M, Testa J, and Pass H. Molecular Biology of Mesothelioma in Cancer: Principles and Practice of Oncology. Sixth Edition. DeVita, Hellman and Rosenberg, eds., Lippincott,Philadelphia (2000),

63. Temeck B and Pass H. Pleural and Pericardial Effusions. In Surgical Oncology. Bland, K, Daly J, and Karakousis, C. McGraw Hill, New York. 2000.

64. Pass H, Edell E, Cortese D, and Kato, H. The Use of Light for the Early Detection and Treatment of Early Lung Cancer. In: Lung Cancer: Principles and Practice. Second Edition. Pass, H.I., Mitchell, J.B., Johnson, D., Turissi, A., Minna J (eds). J. B. Lippincott, Co., Philadelphia (2000).

65. Albain, K and Pass H: Induction Therapy for Locally Advanced Non-Small Cell Lung Cancer. In : Lung Cancer: Principles and Practice. Second Edition. Pass, H.I., Mitchell, J.B., Johnson, D., Turissi, A., Minna J (eds). J. B. Lippincott, Co., Philadelphia (2000).

66. Pass H: Photodynamic Therapy for Early Stage Lung Cancer. In Atlas of Cancer. Markman M. Current Medicine, Inc, Philadelphia, 2003

67. Pass H and Carbone M: Mesothelioma. In Atlas of Cancer. Markman M. Current Medicine, Inc, Philadelphia, 2003

68. Mesothelioma. Pass HI (ed) . In Current Treatment Options in Oncology. Ettinger DS and McVie JG (eds). Volume 1:4: 293-328, 2000.

69. Thoracic Complications of AIDS. Pass HI (ed) in Seminars in Thoracic and Cardiovascular Surgery. Cox JL (ed). Volume 12: 2: 130-153, 2000

70. Pass HI, Hadjiev O, and Carbone M. Animal Models of Mesothelioma in Tumor Models in Cancer Research, Bevery Teicher PhD (ed).The Humana Press Inc.Totowa, NJ, 2001.

71. Pass HI: Mesothelioma in Current Practices in Cardiothoracic Surgery, Yang S Editor, Saunders, due 2003.

Films

1. Pass H, Hardy J, and Acchord J: Zollinger Ellison Syndrome of the pancreas and antrum. Two Primaries. Presented at the Film Session, the American College of Surgeons Meeting, Atlanta, Georgia 1980,and San Francisco, 1984.

2. Pass H, Miser J, Roth J, Kinsella T, and Triche T: Resection of the unresectable chest wall sarcoma following multi-modality treatment. Film Session, American College ofSurgeons, 1985, Chicago and Film Session, Society of Thoracic Surgeons, 1986, Washington DC.

3. Pass H, Stephenson K, Longo D, Glatstein E, and Roth J: Obliteration of postpneumonectomy bronchopleural fistula by tailored thoracoplasty andmuscle transposition. Film Session, American College of Surgeons, 1986.

4. Pass H, Delaney T, Russo A: Sleeve lobectomy after photodynamic therapy of the bronchus. Society of Thoracic Surgeons, 1987.

5. Pass H and Delaney T: Photodynamic Therapy. Video Journal of Oncology. Vol IV, 2, 1990.

6. Pass H: Resection of Embryonal Cell Cancer after Chemotherapy. Video Journal of Thoracic Surgery. 1998

Patients

Patent Number 5,298,742: Light sensor for photo-dynamic therapy having a transparent housing, March 29, 1994

Presentations

Over 300 regional, national and international presentations (list available upon request)